Fund shareholders of KYMERA THERAPEUTICS INC
ISIN US5015751044 · United States
- Fund shareholders
- 364
- Of which ETFs
- 67 297 other funds
- Value held
- ≈ 4.4B $ 4.4B $ · 14.3M SEK
- Share of capital
- 49.3 % of 83.2M shares on Jul 31, 2026
364 funds hold this company. This table lists the 363 that declare it in a regulatory filing. 1 more fund publishes its holdings in its own report. The “Fund reports” tab lists it, with its weight.
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| T. Rowe Price New Horizons Fund, Inc. T. ROWE PRICE NEW HORIZONS FUND, INC. | 2,257,207 | 258.8M $ | 1.76 % | 2.71 % | as of Jun 30, 2026 ↗ |
| Fidelity Growth Company Fund Fidelity Mt. Vernon Street Trust | 2,185,407 | 177.9M $ | 0.18 % | 2.63 % | as of May 31, 2026 ↗ |
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 2,089,249 | 239.6M $ | 0.01 % | 2.51 % | as of Jun 30, 2026 ↗ |
| T. Rowe Price Capital Appreciation Fund T. ROWE PRICE CAPITAL APPRECIATION FUND, INC. | 2,046,104 | 234.6M $ | 0.33 % | 2.46 % | as of Jun 30, 2026 ↗ |
| VANGUARD HEALTH CARE FUND VANGUARD SPECIALIZED FUNDS | 1,796,469 | 185.8M $ | 0.49 % | 2.16 % | as of Jul 31, 2026 ↗ |
| iShares Russell 2000 ETF iShares Trust | 1,607,649 | 184.3M $ | 0.22 % | 1.93 % | as of Jun 30, 2026 ↗ |
| VANGUARD SMALL-CAP INDEX FUND VANGUARD INDEX FUNDS | 1,509,757 | 173.1M $ | 0.09 % | 1.82 % | as of Jun 30, 2026 ↗ |
| SMALLCAP World Fund Inc SMALLCAP World Fund Inc | 1,352,248 | 155.1M $ | 0.16 % | 1.63 % | as of Jun 30, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST | 1,272,754 | 145.9M $ | 1.36 % | 1.53 % | as of Jun 30, 2026 ↗ |
| T. Rowe Price Health Sciences Fund, Inc. T. ROWE PRICE HEALTH SCIENCES FUND, INC. | 924,967 | 106.1M $ | 0.89 % | 1.11 % | as of Jun 30, 2026 ↗ |
| VANGUARD SMALL-CAP GROWTH INDEX FUND VANGUARD INDEX FUNDS | 868,915 | 99.6M $ | 0.21 % | 1.04 % | as of Jun 30, 2026 ↗ |
| T. Rowe Price Small-Cap Stock Fund, Inc. T. ROWE PRICE SMALL-CAP STOCK FUND, INC. | 790,093 | 90.6M $ | 0.97 % | 0.95 % | as of Jun 30, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 726,545 | 83.3M $ | 0.09 % | 0.87 % | as of Jun 30, 2026 ↗ |
| VANGUARD EXPLORER FUND VANGUARD EXPLORER FUND | 693,227 | 71.7M $ | 0.32 % | 0.83 % | as of Jul 31, 2026 ↗ |
| Fidelity Small Cap Index Fund Fidelity Salem Street Trust | 684,750 | 70.8M $ | 0.21 % | 0.82 % | as of Jul 31, 2026 ↗ |
| T. Rowe Price All-Cap Opportunities Fund T. Rowe Price All-Cap Opportunities Fund, Inc. | 660,942 | 75.8M $ | 0.52 % | 0.79 % | as of Jun 30, 2026 ↗ |
| Fidelity Growth Company K6 Fund Fidelity Mt. Vernon Street Trust | 606,740 | 49.4M $ | 0.18 % | 0.73 % | as of May 31, 2026 ↗ |
| T. Rowe Price Integrated U.S. Small-Cap Growth Equity Fund T. ROWE PRICE INTEGRATED EQUITY FUNDS, INC. | 567,076 | 65M $ | 0.66 % | 0.68 % | as of Jun 30, 2026 ↗ |
| Select Biotechnology Portfolio Fidelity Select Portfolios | 556,441 | 45.3M $ | 0.86 % | 0.67 % | as of May 31, 2026 ↗ |
| Fidelity Series Growth Company Fund Fidelity Mt. Vernon Street Trust | 531,529 | 43.3M $ | 0.18 % | 0.64 % | as of May 31, 2026 ↗ |
| iShares Biotechnology ETF iShares Trust | 504,074 | 57.8M $ | 0.64 % | 0.61 % | as of Jun 30, 2026 ↗ |
| Eventide Healthcare & Life Sciences Fund MUTUAL FUND SERIES TRUST | 503,000 | 57.7M $ | 3.22 % | 0.60 % | as of Jun 30, 2026 ↗ |
| iShares Russell 2000 Growth ETF iShares Trust | 477,706 | 54.8M $ | 0.36 % | 0.57 % | as of Jun 30, 2026 ↗ |
| T. Rowe Price Mid-Cap Growth Fund, Inc. T. ROWE PRICE MID-CAP GROWTH FUND, INC. | 467,146 | 53.6M $ | 0.23 % | 0.56 % | as of Jun 30, 2026 ↗ |
| Federated Hermes Kaufmann Fund Federated Hermes Equity Funds | 455,212 | 47.1M $ | 0.96 % | 0.55 % | as of Jul 31, 2026 ↗ |
| Select Health Care Portfolio Fidelity Select Portfolios | 450,000 | 36.6M $ | 0.63 % | 0.54 % | as of May 31, 2026 ↗ |
| JNL/T. Rowe Price Capital Appreciation Fund JNL Series Trust | 446,936 | 51.3M $ | 0.33 % | 0.54 % | as of Jun 30, 2026 ↗ |
| T. Rowe Price Institutional Small-Cap Stock Fund T. Rowe Price Equity Funds, Inc. | 427,717 | 49M $ | 0.98 % | 0.51 % | as of Jun 30, 2026 ↗ |
| VIP Contrafund Portfolio Variable Insurance Products Fund II | 396,100 | 45.4M $ | 0.15 % | 0.48 % | as of Jun 30, 2026 ↗ |
| Fidelity Contrafund Fidelity Contrafund | 380,242 | 43.6M $ | 0.02 % | 0.46 % | as of Jun 30, 2026 ↗ |
| Fidelity Advisor New Insights Fund Fidelity Contrafund | 350,900 | 40.2M $ | 0.14 % | 0.42 % | as of Jun 30, 2026 ↗ |
| Fidelity Small Cap Growth Fund Fidelity Securities Fund | 330,653 | 34.2M $ | 0.39 % | 0.40 % | as of Jul 31, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 317,300 | 25.8M $ | 0.06 % | 0.38 % | as of May 31, 2026 ↗ |
| Fidelity Stock Selector Small Cap Fund Fidelity Capital Trust | 314,000 | 32.5M $ | 0.44 % | 0.38 % | as of Jul 31, 2026 ↗ |
| Putnam Small Cap Growth Fund Putnam Funds Trust | 307,841 | 35.3M $ | 1.04 % | 0.37 % | as of Jun 30, 2026 ↗ |
| Schwab U.S. Small-Cap ETF SCHWAB STRATEGIC TRUST | 294,706 | 24M $ | 0.11 % | 0.35 % | as of May 31, 2026 ↗ |
| VANGUARD RUSSELL 2000 INDEX FUND VANGUARD SCOTTSDALE FUNDS | 294,549 | 24M $ | 0.14 % | 0.35 % | as of May 31, 2026 ↗ |
| Federated Hermes Kaufmann Small Cap Fund Federated Hermes Equity Funds | 284,366 | 29.4M $ | 1.03 % | 0.34 % | as of Jul 31, 2026 ↗ |
| Strategic Advisers Fidelity U.S. Total Stock Fund Fidelity Rutland Square Trust II | 255,700 | 20.8M $ | 0.01 % | 0.31 % | as of May 31, 2026 ↗ |
| AB Small Cap Growth Portfolio AB CAP FUND, INC. | 242,969 | 27.9M $ | 0.89 % | 0.29 % | as of Jun 30, 2026 ↗ |
| Fidelity Advisor Biotechnology Fund Fidelity Advisor Series VII | 231,700 | 24M $ | 1.09 % | 0.28 % | as of Jul 31, 2026 ↗ |
| Fidelity Advisor Health Care Fund Fidelity Advisor Series VII | 228,000 | 23.6M $ | 0.76 % | 0.27 % | as of Jul 31, 2026 ↗ |
| Fidelity Series Small Cap Opportunities Fund Fidelity Securities Fund | 221,000 | 22.9M $ | 0.48 % | 0.27 % | as of Jul 31, 2026 ↗ |
| VY(R) T. ROWE PRICE CAPITAL APPRECIATION PORTFOLIO Voya Investors Trust | 217,017 | 24.9M $ | 0.36 % | 0.26 % | as of Jun 30, 2026 ↗ |
| PGIM Jennison Health Sciences Fund Prudential Sector Funds, Inc. | 215,651 | 17.6M $ | 1.26 % | 0.26 % | as of May 29, 2026 ↗ |
| AB DISCOVERY GROWTH FUND, INC. AB DISCOVERY GROWTH FUND, INC. | 197,291 | 22.6M $ | 0.78 % | 0.24 % | as of Jun 30, 2026 ↗ |
| Fidelity Series Opportunistic Insights Fund Fidelity Contrafund | 195,100 | 22.4M $ | 0.15 % | 0.23 % | as of Jun 30, 2026 ↗ |
| Fidelity Small Cap Growth K6 Fund Fidelity Securities Fund | 165,058 | 17.1M $ | 0.37 % | 0.20 % | as of Jul 31, 2026 ↗ |
| Fidelity SAI Small-Mid Cap Momentum Index Fund Fidelity Salem Street Trust | 159,731 | 16.5M $ | 0.40 % | 0.19 % | as of Jul 31, 2026 ↗ |
| Dimensional U.S. Small Cap ETF Dimensional ETF Trust | 152,728 | 15.8M $ | 0.10 % | 0.18 % | as of Jul 31, 2026 ↗ |
| Schwab Small-Cap Index Fund SCHWAB CAPITAL TRUST | 152,115 | 15.7M $ | 0.21 % | 0.18 % | as of Jul 31, 2026 ↗ |
| Fidelity Balanced Fund Fidelity Puritan Trust | 149,044 | 12.1M $ | 0.02 % | 0.18 % | as of May 31, 2026 ↗ |
| Driehaus Small Cap Growth Fund Driehaus Mutual Funds | 148,076 | 17M $ | 1.05 % | 0.18 % | as of Jun 30, 2026 ↗ |
| Fidelity U.S. Equity Central Fund Fidelity Central Investment Portfolios LLC | 145,000 | 16.6M $ | 0.07 % | 0.17 % | as of Jun 30, 2026 ↗ |
| Penn Series Flexibly Managed Fund Penn Series Funds Inc | 144,575 | 16.6M $ | 0.34 % | 0.17 % | as of Jun 30, 2026 ↗ |
| VANGUARD HEALTH CARE INDEX FUND VANGUARD WORLD FUND | 143,130 | 11.7M $ | 0.06 % | 0.17 % | as of May 31, 2026 ↗ |
| ClearBridge Small Cap Growth Fund Legg Mason Partners Investment Trust | 136,100 | 14.1M $ | 0.74 % | 0.16 % | as of Jul 31, 2026 ↗ |
| MFS New Discovery Fund MFS SERIES TRUST I | 133,236 | 10.8M $ | 0.51 % | 0.16 % | as of May 31, 2026 ↗ |
| Bridge Builder Small/Mid Cap Growth Fund Bridge Builder Trust | 128,948 | 14.8M $ | 0.13 % | 0.16 % | as of Jun 30, 2026 ↗ |
| T. Rowe Price Capital Appreciation Equity ETF T. Rowe Price Exchange-Traded Funds, Inc. | 128,781 | 14.8M $ | 0.20 % | 0.15 % | as of Jun 30, 2026 ↗ |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 119,516 | 9.7M $ | 0.01 % | 0.14 % | as of May 31, 2026 ↗ |
| U.S. SMALL CAP PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 117,742 | 12.2M $ | 0.06 % | 0.14 % | as of Jul 31, 2026 ↗ |
| Fidelity Blue Chip Growth Fund Fidelity Securities Fund | 115,600 | 12M $ | 0.01 % | 0.14 % | as of Jul 31, 2026 ↗ |
| Master Small Cap Index Series Quantitative Master Series LLC | 115,474 | 13.2M $ | 0.22 % | 0.14 % | as of Jun 30, 2026 ↗ |
| Dimensional U.S. Core Equity 2 ETF Dimensional ETF Trust | 113,415 | 11.7M $ | 0.02 % | 0.14 % | as of Jul 31, 2026 ↗ |
| JNL Multi-Manager Small Cap Growth Fund JNL Series Trust | 109,987 | 12.6M $ | 0.50 % | 0.13 % | as of Jun 30, 2026 ↗ |
| LORD ABBETT DEVELOPING GROWTH FUND INC LORD ABBETT DEVELOPING GROWTH FUND, INC. | 108,430 | 11.2M $ | 0.50 % | 0.13 % | as of Jul 31, 2026 ↗ |
| Voya Small Cap Growth Fund Voya Equity Trust | 104,596 | 8.5M $ | 0.40 % | 0.13 % | as of May 31, 2026 ↗ |
| T. Rowe Price Diversified Mid-Cap Growth Fund, Inc. T. ROWE PRICE DIVERSIFIED MID-CAP GROWTH FUND, INC. | 102,098 | 11.7M $ | 0.24 % | 0.12 % | as of Jun 30, 2026 ↗ |
| iShares Russell 2000 Value ETF iShares Trust | 100,987 | 11.6M $ | 0.08 % | 0.12 % | as of Jun 30, 2026 ↗ |
| T. Rowe Price Small-Mid Cap ETF T. Rowe Price Exchange-Traded Funds, Inc. | 100,832 | 11.6M $ | 0.43 % | 0.12 % | as of Jun 30, 2026 ↗ |
| EQ/AB Small Cap Growth Portfolio EQ Advisors Trust | 97,895 | 11.2M $ | 0.50 % | 0.12 % | as of Jun 30, 2026 ↗ |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 93,966 | 7.7M $ | 0.01 % | 0.11 % | as of May 31, 2026 ↗ |
| JNL/T. Rowe Price Mid-Cap Growth Fund JNL Series Trust | 93,718 | 10.7M $ | 0.25 % | 0.11 % | as of Jun 30, 2026 ↗ |
| Fidelity Advisor Small Cap Fund Fidelity Advisor Series I | 88,400 | 7.2M $ | 0.30 % | 0.11 % | as of May 31, 2026 ↗ |
| VIP Health Care Portfolio Variable Insurance Products Fund IV | 85,958 | 9.9M $ | 0.85 % | 0.10 % | as of Jun 30, 2026 ↗ |
| T. Rowe Price Small-Cap Value Fund, Inc. T. ROWE PRICE SMALL-CAP VALUE FUND, INC. | 85,122 | 9.8M $ | 0.09 % | 0.10 % | as of Jun 30, 2026 ↗ |
| Select Pharmaceuticals Portfolio Fidelity Select Portfolios | 84,500 | 6.9M $ | 0.46 % | 0.10 % | as of May 31, 2026 ↗ |
| ALPS Medical Breakthroughs ETF ALPS ETF TRUST | 84,154 | 6.9M $ | 4.23 % | 0.10 % | as of May 31, 2026 ↗ |
| Nuveen Small Cap Blend Index Fund TIAA-CREF Funds | 81,699 | 8.4M $ | 0.21 % | 0.10 % | as of Jul 31, 2026 ↗ |
| iShares Core S&P Total U.S. Stock Market ETF iShares Trust | 81,326 | 9.3M $ | 0.01 % | 0.10 % | as of Jun 30, 2026 ↗ |
| Fidelity Contrafund K6 Fidelity Contrafund | 81,026 | 9.3M $ | 0.02 % | 0.10 % | as of Jun 30, 2026 ↗ |
| SmallCap Growth Fund I Principal Funds, Inc | 77,794 | 8M $ | 0.32 % | 0.09 % | as of Jul 31, 2026 ↗ |
| AST Small-Cap Equity Portfolio Advanced Series Trust | 74,855 | 8.6M $ | 0.41 % | 0.09 % | as of Jun 30, 2026 ↗ |
| Fidelity Series Small Cap Core Fund Fidelity Concord Street Trust | 70,500 | 7.3M $ | 0.46 % | 0.08 % | as of Jul 31, 2026 ↗ |
| Strategic Advisers U.S. Total Stock Fund Fidelity Rutland Square Trust II | 69,847 | 5.7M $ | 0.01 % | 0.08 % | as of May 31, 2026 ↗ |
| THE HARTFORD SMALL COMPANY FUND HARTFORD MUTUAL FUNDS, INC | 68,176 | 7M $ | 1.05 % | 0.08 % | as of Jul 31, 2026 ↗ |
| EQ/2000 Managed Volatility Portfolio EQ Advisors Trust | 67,956 | 7.8M $ | 0.20 % | 0.08 % | as of Jun 30, 2026 ↗ |
| BlackRock Advantage Small Cap Core Fund BlackRock Funds | 67,237 | 5.5M $ | 0.10 % | 0.08 % | as of May 29, 2026 ↗ |
| T.Rowe Price Small Cap Growth Portfolio Brighthouse Funds Trust II | 66,331 | 7.6M $ | 0.67 % | 0.08 % | as of Jun 30, 2026 ↗ |
| T. Rowe Price Health Sciences Portfolio T. ROWE PRICE EQUITY SERIES, INC. | 58,378 | 6.7M $ | 0.89 % | 0.07 % | as of Jun 30, 2026 ↗ |
| BlackRock Health Sciences Opportunities Portfolio BlackRock Funds | 54,173 | 4.4M $ | 0.07 % | 0.07 % | as of May 29, 2026 ↗ |
| T. Rowe Price Integrated U.S. Small-Mid Cap Core Equity Fund T. ROWE PRICE INTEGRATED EQUITY FUNDS, INC. | 54,116 | 6.2M $ | 0.32 % | 0.07 % | as of Jun 30, 2026 ↗ |
| VANGUARD RUSSELL 2000 GROWTH INDEX FUND VANGUARD SCOTTSDALE FUNDS | 53,856 | 4.4M $ | 0.26 % | 0.06 % | as of May 31, 2026 ↗ |
| T. Rowe Price Institutional Mid-Cap Equity Growth Fund T. Rowe Price Equity Funds, Inc. | 53,451 | 6.1M $ | 0.24 % | 0.06 % | as of Jun 30, 2026 ↗ |
| Fidelity Fund Fidelity Hastings Street Trust | 52,700 | 6M $ | 0.07 % | 0.06 % | as of Jun 30, 2026 ↗ |
| Fidelity Enhanced Small Cap Core ETF Fidelity Covington Trust | 50,241 | 5.8M $ | 0.10 % | 0.06 % | as of Jun 30, 2026 ↗ |
| VANGUARD TOTAL WORLD STOCK INDEX FUND VANGUARD INTERNATIONAL EQUITY INDEX FUNDS | 49,584 | 5.1M $ | 0.01 % | 0.06 % | as of Jul 31, 2026 ↗ |
| U.S. CORE EQUITY 2 PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 49,402 | 5.1M $ | 0.01 % | 0.06 % | as of Jul 31, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 49,216 | 4M $ | 0.01 % | 0.06 % | as of May 31, 2026 ↗ |
Funds that publish their own holdings
| Fund | Weight in fund | |
|---|---|---|
| Pictet - Biotech Pictet Asset Management (Europe) S.A. | 0.58 % | as of Sep 30, 2025 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| ALPS Medical Breakthroughs ETF ALPS ETF TRUST | 4.23 % | as of May 31, 2026 ↗ |
| Eventide Healthcare & Life Sciences Fund MUTUAL FUND SERIES TRUST | 3.22 % | as of Jun 30, 2026 ↗ |
| AMG Frontier Small Cap Growth Fund AMG Funds I | 2.26 % | as of Jul 31, 2026 ↗ |
| Harbor Human Capital Factor US Small Cap ETF Harbor ETF Trust | 2.21 % | as of Jul 31, 2026 ↗ |
| Baron Health Care Fund BARON SELECT FUNDS | 2.01 % | as of Jun 30, 2026 ↗ |
| Fidelity Disruptive Medicine ETF Fidelity Covington Trust | 1.99 % | as of May 31, 2026 ↗ |
| T. Rowe Price New Horizons Fund, Inc. T. ROWE PRICE NEW HORIZONS FUND, INC. | 1.76 % | as of Jun 30, 2026 ↗ |
| Global X Guru Index ETF GLOBAL X FUNDS | 1.41 % | as of Jul 31, 2026 ↗ |
| WCM Small Cap Growth Fund INVESTMENT MANAGERS SERIES TRUST | 1.41 % | as of Jun 30, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST | 1.36 % | as of Jun 30, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q3 | 362 | +36 | 41,010,138 | +9.7 % |
| 2026Q2 | 326 | +46 | 37,368,607 | +19.2 % |
| 2026Q1 | 280 | +34 | 31,349,132 | +16.0 % |
| 2025Q4 | 246 | +17 | 27,025,402 | +2.7 % |
| 2025Q3 | 229 | +20 | 26,320,167 | +5.4 % |
| 2025Q2 | 209 | -17 | 24,978,847 | +3.3 % |
| 2025Q1 | 226 | -3 | 24,181,745 | -0.4 % |
| 2024Q4 | 229 | +7 | 24,277,044 | +9.0 % |
| 2024Q3 | 222 | +8 | 22,274,447 | -1.1 % |
| 2024Q2 | 214 | +9 | 22,529,228 | +36.8 % |
| 2024Q1 | 205 | -9 | 16,467,458 | -17.7 % |
| 2023Q4 | 214 | 20,020,316 |
Institutional managers
248 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| FMR LLC | 11,699,950 | 974.5M $ | as of Mar 31, 2026 |
| BAKER BROS. ADVISORS LP | 8,657,242 | 721.1M $ | as of Mar 31, 2026 |
| Avoro Capital Advisors LLC | 7,474,747 | 622.6M $ | as of Mar 31, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 6,060,847 | 504.8K $ | as of Mar 31, 2026 |
| BVF INC/IL | 5,502,710 | 458.3M $ | as of Mar 31, 2026 |
| T. Rowe Price Investment Management, Inc. | 5,464,997 | 455.2K $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 5,060,876 | 421.5M $ | as of Mar 31, 2026 |
| Atlas Venture Life Science Advisors, LLC | 4,578,008 | 381.3M $ | as of Mar 31, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | 3,889,687 | 324M $ | as of Mar 31, 2026 |
| Siren, L.L.C. | 3,186,830 | 265.4M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 2,389,767 | 199M $ | as of Mar 31, 2026 |
| Capital Research Global Investors | 1,673,275 | 139.4M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 1,645,350 | 137.1M $ | as of Mar 31, 2026 |
| Driehaus Capital Management LLC | 1,043,583 | 86.9M $ | as of Mar 31, 2026 |
| UBS Group AG | 1,023,852 | 85.3M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 888,409 | 74M $ | as of Mar 31, 2026 |
| ALLIANCEBERNSTEIN L.P. | 888,035 | 69.1M $ | as of Mar 31, 2026 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 875,872 | 73M $ | as of Mar 31, 2026 |
| Holocene Advisors, LP | 836,759 | 69.7M $ | as of Mar 31, 2026 |
| Merck & Co., Inc. | 772,165 | 64.3M $ | as of Mar 31, 2026 |
| FRONTIER CAPITAL MANAGEMENT CO LLC | 759,848 | 63.3M $ | as of Mar 31, 2026 |
| Commodore Capital LP | 750,000 | 62.5M $ | as of Mar 31, 2026 |
| EVENTIDE ASSET MANAGEMENT, LLC | 626,925 | 52.2M $ | as of Mar 31, 2026 |
| DIMENSIONAL FUND ADVISORS LP | 592,879 | 49.4M $ | as of Mar 31, 2026 |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 561,170 | 46.7M $ | as of Mar 31, 2026 |
Declared shareholders of KYMERA THERAPEUTICS INC
There are 2 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| T. Rowe Price Associates, Inc. | 10.70 % | 8,873,588 | as of Aug 31, 2026 · SCHEDULE 13G |
| Atlas Venture Fund X, L.P. and 5 others | 2.90 % | 2,384,685 | as of Jun 30, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Fund shareholders of KYMERA THERAPEUTICS INC". https://titelia.com/en/stocks/kymera-therapeutics-inc-US5015751044